1. |
Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 2019, 16(10): 589-604.
|
2. |
Tanaka M, Katayama F, Kato H, et al. Hepatitis B and C virus infection and hepatocellular carcinoma in China: A review of epidemiology and control measures. J Epidemiol, 2011, 21(6): 401-416.
|
3. |
Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control, 2017, 24(3): 1073274817729245.
|
4. |
Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific Clinical Practice Guidelines on the management of hepatocellular carcinoma: A 2017 update. Hepatol Int, 2017, 11(4): 317-370.
|
5. |
Lee EC, Kim SH, Park H, et al. Survival analysis after liver resection for hepatocellular carcinoma: a consecutive cohort of 1 002 patients. J Gastroenterol Hepatol, 2017, 32(5): 1055-1063.
|
6. |
Zhou YM, Zhang XF, Li B, et al. Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection. BMC Cancer, 2015, 15: 689.
|
7. |
Yang JD, Mohamed HA, Cvinar JL, et al. Diabetes mellitus heightens the risk of hepatocellular carcinoma except in patients with hepatitis C cirrhosis. Am J Gastroenterol, 2016, 111(11): 1573-1580.
|
8. |
Reeves HL, Zaki MY, Day CP. Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD. Dig Dis Sci, 2016, 61(5): 1234-1245.
|
9. |
El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol, 2006, 4(3): 369-380.
|
10. |
Lawson DH, Gray JM, McKillop C, et al. Diabetes mellitus and primary hepatocellular carcinoma. Q J Med, 1986, 61(234): 945-955.
|
11. |
Dhar D, Seki E, Karin M. NCOA5, IL-6, type 2 diabetes, and HCC: the deadly quartet. Cell Metab, 2014, 19(1): 6-7.
|
12. |
Gao S, Li A, Liu F, et al. NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell, 2013, 24(6): 725-737.
|
13. |
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版). 中华消化外科杂志, 2017, 16(7): 635-647.
|
14. |
Colecchia A, Schiumerini R, Cucchetti A, et al. Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol, 2014, 20(20): 5935-5950.
|
15. |
张福鑫, 郑扬, 涂攀. 完全腹腔镜术治疗开腹术后复发性肝细胞肝癌的疗效、安全性及预后分析. 中华普外科手术学杂志(电子版), 2019, 13(3): 244-246.
|
16. |
Jin B, Zhou BH, Hu SY. Liver exposure using sterile glove pouch during laparoscopic right liver surgery in hepatocellular carcinoma patients. World J Surg, 2016, 40(4): 946-950.
|
17. |
Alizadeh N, Khalili H, Mohammadi M, et al. Effect of vitamin D on stress-induced hyperglycaemia and insulin resistance in critically ill patients. Int J Clin Pract, 2016, 70(5): 396-405.
|
18. |
Liu SR, Chao R, Liang P, et al. Diabetes mellitus may worsen the prognosis in hepatocellular carcinoma patients undergoing curative microwave ablation. J BUON, Jul-Aug, 2018, 23(4): 958-964.
|
19. |
Choi Y, Choi Y, Choi CS, et al. Diabetes mellitus increases the risk of intrahepatic recurrence of hepatocellular carcinoma after surgical resection. Tumori, 2017, 103(3): 279-285.
|
20. |
Li X, Wang X, Gao P. Diabetes mellitus and risk of hepatocellular carcinoma. Biomed Res Int, 2017, 2017: 5202684.
|
21. |
Tan Y, Wei S, Zhang W, et al. Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review. Cancer Manag Res, 2019, 11: 705-713.
|
22. |
刘通, 刘海, 金鹏飞, 等. 空腹血糖与肝癌发病关系的多中心回顾性研究(附94 264例报告). 中华消化外科杂志, 2019, 18(4): 348-357.
|
23. |
钟秋安, 仇小强, 蒋俊俊, 等. 糖尿病与原发性肝癌关系队列研究的Meta分析. 肿瘤防治研究, 2010, 37(1): 97-100.
|
24. |
Chen WT, Macatula TC, Lin CC, et al. Diabetes may not affect outcomes in hepatocellular carcinoma after radio-frequency ablation. Hepatogastroenterology, , 2011, 58(106): 551-557.
|
25. |
Komura T, Mizukoshi E, Kita Y, et al. Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis. Am J Gastroenterol, 2007, 102(9): 1939-1946.
|
26. |
Hosokawa T, Kurosaki M, Tsuchiya K, et al. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy. World J Gastroenterol, 2013, 19(2): 249-257.
|
27. |
Yu W, Wang Y, Liao G. Blood sugar level affects the recurrence of hepatocellular carcinoma after laparoscopic surgery: a retrospective study. J BUON, 2018, 23(3): 622-628.
|
28. |
蔡庆, 孙世波, 钟锋, 等. 肝癌根治性切除术后高血糖与肝癌复发的相关因素分析. 中华消化外科杂志, 2016, 15(1): 47-52.
|
29. |
Li W, Liu H, Qian W, et al. Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer. Comput Struct Biotechnol J, 2018, 16: 479-487.
|
30. |
Hua F, Yu JJ, Hu ZW. Diabetes and cancer, common threads and missing links. Cancer Lett, 2016, 374(1): 54-61.
|
31. |
Yan XD, Yao M, Wang L, et al. Overexpression of insulin-like growth factor-Ⅰ receptor as a pertinent biomarker for hepatocytes malignant transformation. World J Gastroenterol, 2013, 19(36): 6084-6092.
|
32. |
De Matteis S, Ragusa A, Marisi G, et al. Aberrant metabolism in hepatocellular carcinoma provides diagnostic and therapeutic opportunities. Oxid Med Cell Longev, 2018, 2018: 7512159.
|
33. |
李文洁, 商春雨, 桑慧, 等. 糖尿病与恶性肿瘤关系的研究进展. 消化肿瘤杂志(电子版), 2019, 11(3): 185-189.
|
34. |
Chen HL, OuYang HY, Le Y, et al. Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy. Cancer Med, 2018, 7(11): 5339-5350.
|
35. |
Kim SH, Moon DB, Kim WJ, et al. Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-Ⅱ (PIVKA-Ⅱ) in patients with hepatocellular carcinoma for living donor liver transplantation. Hepatobiliary Surg Nutr, 2016, 5(6): 461-469.
|
36. |
Parissa T, Ghalib J, Brian S, et al. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg, 2015, 261(5): 947-955.
|
37. |
朱倩, 乔国梁, 晏建军, 等. 乙肝肝硬化相关早期肝癌切除术预后. 中华肝胆外科杂志, 2014, 20(4): 258-264.
|
38. |
罗鸿昌, 张婷婷, 张伟, 等. 超声引导下经皮微波消融治疗肝细胞性肝癌术后复发灶远期疗效评估. 影像诊断与介入放射学, 2014, 23(5): 367-370.
|